iTeos Therapeutics
ITOS
$22.25
Share price
-1.64%
Change (1 day)
-37.02%
Change (1 year)
Categories
Revenue for iTeos Therapeutics (ITOS)
Revenue in 2022 (TTM): $0.45 B
According to iTeos Therapeutics's latest financial reports the company's current revenue (TTM) is $0.45 B. In 2021 the company made a revenue of $0.34 B an increase over the years 2020 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for iTeos Therapeutics from 2019 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $0.45 B | 31.75% |
| 2021 | $0.34 B | INF% |
| 2020 | N/A | NAN% |
| 2019 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | -100.00% | 🇺🇸 USA |